Nkarta Inc (NKTX)
6.52
-0.30
(-4.40%)
USD |
NASDAQ |
May 17, 16:00
6.52
0.00 (0.00%)
After-Hours: 20:00
Nkarta Shareholders Equity (Quarterly): 473.65M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 473.65M |
| December 31, 2023 | 273.28M |
| September 30, 2023 | 296.82M |
| June 30, 2023 | 317.98M |
| March 31, 2023 | 346.65M |
| December 31, 2022 | 372.21M |
| September 30, 2022 | 399.26M |
| June 30, 2022 | 421.04M |
| March 31, 2022 | 228.71M |
| Date | Value |
|---|---|
| December 31, 2021 | 250.97M |
| September 30, 2021 | 270.01M |
| June 30, 2021 | 288.38M |
| March 31, 2021 | 305.99M |
| December 31, 2020 | 321.22M |
| September 30, 2020 | 334.98M |
| June 30, 2020 | -83.89M |
| March 31, 2020 | 26.12M |
| December 31, 2019 | -25.48M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-83.89M
Minimum
Jun 2020
473.65M
Maximum
Mar 2024
267.66M
Average
301.40M
Median
Shareholders Equity (Quarterly) Benchmarks
| Cutera Inc | -192.56M |
| GT Biopharma Inc | 7.476M |
| Outlook Therapeutics Inc | -134.24M |
| IMAC Holdings Inc | -0.7526M |
| Capricor Therapeutics Inc | 18.43M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 576.94M |
| Total Liabilities (Quarterly) | 103.28M |